Rare constituents of the nasal microbiome contribute to the acute exacerbation of chronic rhinosinusitis
- PMID: 39797944
- DOI: 10.1007/s00011-025-01995-9
Rare constituents of the nasal microbiome contribute to the acute exacerbation of chronic rhinosinusitis
Abstract
Background: Dysbiosis of the nasal microbiome is considered to be related to the acute exacerbation of chronic rhinosinusitis (AECRS). The microbiota in the nasal cavity of AECRS patients and its association with disease severity has rarely been studied. This study aimed to characterize nasal dysbiosis in a prospective cohort of patients with AECRS.
Methods: We performed a cross-sectional study of 28 patients with AECRS, 20 patients with chronic rhinosinusitis (CRS) without acute exacerbation (AE), and 29 healthy controls using 16S rRNA gene sequencing. Subjective and objective assessments of CRS disease severity during AE were also collected.
Results: Compared to healthy controls and patients with CRS without AE, AECRS presented with a substantial decrease of the Corynebacterium_1 and a significant increase of Ralstonia and Acinetobacter at the genus level (LDA score > 2.0 [P < 0.05]). Furthermore, genera with a mean relative abundance (MRA) of less than 1% were defined as rare components based on published studies, then 29 genera with a substantial alteration in AECRS were rare constituents of the microbiome, of which 18 rare genera were highly associated with subjective and objective disease severity. Moreover, a combination of 15 genera could differentiate patients with AECRS with an area under the curve of 0.870 (95% CI = 0.784-0.955). Prediction of microbial functional pathways involved significantly enhanced lipopolysaccharide biosynthesis pathways and significantly decreased folate biosynthesis, sulfur relay system, and cysteine and methionine metabolism pathways in patients with AECRS.
Conclusions: The rare nasal microbiota (MRA < 1%) correlated with disease status and disease severity in patients with AECRS. The knowledge about the pattern of the nasal microbiome and its metabolomic pathway may contribute to the fundamental understanding of AECRS pathophysiology.
Keywords: Acute exacerbation; Chronic rhinosinusitis; Disease severity; Dysbiosis; Nasal microbiome; Prediction.
© 2025. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: This study was approved by the Peking University Third Hospital Ethics Committee (Number 2020100X).
Similar articles
-
Distinct inflammatory patterns and nasal bacterial dysbiosis in uncontrolled chronic rhinosinusitis.Eur Arch Otorhinolaryngol. 2025 Jun;282(6):3085-3096. doi: 10.1007/s00405-025-09376-y. Epub 2025 Apr 16. Eur Arch Otorhinolaryngol. 2025. PMID: 40234310
-
Amoxicillin-clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double-blinded, placebo-controlled trial.Int Forum Allergy Rhinol. 2017 Feb;7(2):135-142. doi: 10.1002/alr.21846. Epub 2016 Sep 9. Int Forum Allergy Rhinol. 2017. PMID: 27610609 Clinical Trial.
-
Evidence of microbiota dysbiosis in chronic rhinosinusitis.Int Forum Allergy Rhinol. 2017 Mar;7(3):230-239. doi: 10.1002/alr.21871. Epub 2016 Nov 23. Int Forum Allergy Rhinol. 2017. PMID: 27879060
-
Next Generation Sequencing and the Microbiome of Chronic Rhinosinusitis: A Primer for Clinicians and Review of Current Research, Its Limitations, and Future Directions.Ann Otol Rhinol Laryngol. 2016 Aug;125(8):613-21. doi: 10.1177/0003489416641429. Epub 2016 Apr 7. Ann Otol Rhinol Laryngol. 2016. PMID: 27056556 Review.
-
The Microbiome and Chronic Rhinosinusitis.Immunol Allergy Clin North Am. 2020 May;40(2):251-263. doi: 10.1016/j.iac.2019.12.009. Epub 2020 Jan 16. Immunol Allergy Clin North Am. 2020. PMID: 32278449 Free PMC article. Review.
References
-
- Dawei W, Benjamin SB, Yongxiang W. Definition and characteristics of acute exacerbation in adult patients with chronic rhinosinusitis: a systematic review. J Otolaryngol Head Neck Surg. 2020;49(1):62. - DOI
-
- Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(Suppl S29):1–464. - PubMed
MeSH terms
Substances
Grants and funding
- 82000954/Natural Science Foundation of China
- Z201100006820086/Beijing Science and Technology Nova Program
- QML20190617/Beijing Hospitals Authority Youth Program
- XMLX202136/Beijing Hospitals Authority Clinical Medicine Development of Special Funding
- BYSYZD2023029/Key clinical projects of Peking University Third Hospital
LinkOut - more resources
Full Text Sources
Medical